Kenneth Grossman

884 total citations
8 papers, 108 citations indexed

About

Kenneth Grossman is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Kenneth Grossman has authored 8 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Kenneth Grossman's work include Head and Neck Surgical Oncology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Melanoma and MAPK Pathways (2 papers). Kenneth Grossman is often cited by papers focused on Head and Neck Surgical Oncology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Melanoma and MAPK Pathways (2 papers). Kenneth Grossman collaborates with scholars based in United States. Kenneth Grossman's co-authors include Richard B. Cannon, Ying J. Hitchcock, Luke Buchmann, Shane Lloyd, Marcus M. Monroe, Jason P. Hunt, John R. Weis, Theresa L. Werner, Kenneth M. Boucher and David H. Munn and has published in prestigious journals such as Blood, Cancer Research and The American Journal of Gastroenterology.

In The Last Decade

Kenneth Grossman

8 papers receiving 107 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth Grossman United States	5	46	30	26	18	17	8	108
Reanne Bowlby Canada	4	24 0.5×	28 0.9×	12 0.5×	11 0.6×	22 1.3×	7	69
Hema Gowda United States	6	131 2.8×	32 1.1×	44 1.7×	61 3.4×	10 0.6×	13	176
Joshua Hessler United States	5	31 0.7×	37 1.2×	24 0.9×	47 2.6×	16 0.9×	7	143
Mandeep Hundal United States	3	32 0.7×	38 1.3×	96 3.7×	33 1.8×	24 1.4×	6	185
Ryszard Mężyk Poland	9	51 1.1×	35 1.2×	16 0.6×	11 0.6×	40 2.4×	20	185
Л. Д. Жуйкова Russia	8	53 1.2×	34 1.1×	41 1.6×	22 1.2×	8 0.5×	33	154
Susanna Nguy United States	4	122 2.7×	31 1.0×	102 3.9×	19 1.1×	9 0.5×	9	180
Xiaolong Cheng China	5	35 0.8×	76 2.5×	14 0.5×	19 1.1×	18 1.1×	9	123
Ilian Tchakov United Kingdom	8	149 3.2×	73 2.4×	50 1.9×	33 1.8×	19 1.1×	13	216
Hui Yi Chew Australia	5	36 0.8×	33 1.1×	17 0.7×	38 2.1×	10 0.6×	8	94

Countries citing papers authored by Kenneth Grossman

Since Specialization

Citations

This map shows the geographic impact of Kenneth Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Grossman more than expected).

Fields of papers citing papers by Kenneth Grossman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Grossman. The network helps show where Kenneth Grossman may publish in the future.

Co-authorship network of co-authors of Kenneth Grossman

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Grossman. A scholar is included among the top collaborators of Kenneth Grossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Grossman. Kenneth Grossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Grossman, Kenneth, Wallace Akerley, Kenneth M. Boucher, et al.. (2021). A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker. BMC Cancer. 21(1). 510–510. 38 indexed citations

Algazi, Alain P., Megan Othus, Adil Daud, et al.. (2020). Abstract CT013: SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma. Cancer Research. 80(16_Supplement). CT013–CT013. 4 indexed citations

Grossman, Kenneth, et al.. (2018). Adjuvant therapy for resected high-risk melanoma. Seminars in Cutaneous Medicine and Surgery. 37(2). 109–111. 10 indexed citations

Zakharia, Yousef, Robert R. McWilliams, Kenneth Grossman, et al.. (2017). Abstract CT117: Interim analysis of the Phase 2 clinical trial of the IDO pathway inhibitor indoximod in combination with pembrolizumab for patients with advanced melanoma. Cancer Research. 77(13_Supplement). CT117–CT117. 31 indexed citations

Cannon, Richard B., Luke Buchmann, Jason P. Hunt, et al.. (2016). Increasing use of nonsurgical therapy in advanced‐stage oral cavity cancer: A population‐based study. Head & Neck. 39(1). 82–91. 22 indexed citations

Singh, Prabhsimranjot, et al.. (2016). Steroid Dependent Recalcitrant Well's Syndrome in a Patient with Chronic Lymphocytic Leukemia (CLL) Responding to Hydroxychloroquine (HCQS). Blood. 128(22). 5579–5579. 1 indexed citations

Burt, Lindsay, Richard R. Orlandi, Jason P. Hunt, et al.. (2015). Function preservation and optimal outcomes—definitive chemoradiotherapy with multi-phase treatment planning for locally advanced sinonasal cancer. Journal of Radiation Oncology. 5(1). 47–54. 1 indexed citations

Kanth, Priyanka, Kenneth Grossman, Neeraj Agarwal, et al.. (2012). Cytotoxic T-Lymphocyte-Associated Antigen 4 Antibody (Ipilimumab) Associated Enterocolitis. The American Journal of Gastroenterology. 107. S204–S204. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact